Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions (OTCQB:BNXTF) has announced the continuation of Terry Lynch as capital markets advisor and the retention of two new investor relations professionals. Terry Lynch, CEO of Power Metallic Mines, brings significant early-stage capital markets experience in resource and bioscience sectors.
The company has hired Rob Grace and Blaine Ruzcki for investor relations services for a six-month period. Grace will receive CAD 20,000 monthly while Ruzcki will receive CAD 40,000 monthly, plus GST. Each professional will also receive 1,000,000 stock options exercisable at $0.88 for 18 months, vesting over 12 months according to CSE's mandatory schedule.
BioNxt Solutions (OTCQB:BNXTF) ha annunciato la conferma di Terry Lynch come consulente dei mercati dei capitali e il mantenimento di due nuovi professionisti delle relazioni con gli investitori. Terry Lynch, CEO di Power Metallic Mines, porta una significativa esperienza nei mercati dei capitali nelle fasi iniziali nei settori delle risorse e delle bioscienze.
L’azienda ha assunto Rob Grace e Blaine Ruzcki per servizi di relazioni con gli investitori per un periodo di sei mesi. Grace riceverà CAD 20.000 al mese, mentre Ruzcki riceverà CAD 40.000 al mese, più GST. Ciascun professionista riceverà inoltre 1.000.000 di opzioni azionarie exercitabili a 0,88 CAD per 18 mesi, con vesting computato entro 12 mesi secondo il programma obbligatorio del CSE.
BioNxt Solutions (OTCQB:BNXTF) ha anunciado la continuación de Terry Lynch como asesor de mercados de capital y la contratación de dos nuevos profesionales de relaciones con inversores. Terry Lynch, director ejecutivo de Power Metallic Mines, aporta una experiencia significativa en los mercados de capital en etapas tempranas, en los sectores de recursos y biosciencia.
La empresa ha contratado a Rob Grace y Blaine Ruzcki para servicios de relaciones con inversores por un periodo de seis meses. Grace recibirá CAD 20,000 mensuales mientras que Ruzcki recibirá CAD 40,000 mensuales, más GST. A cada profesional también se le otorgarán 1,000,000 de opciones sobre acciones exercitables a 0,88 CAD durante 18 meses, con vesting en 12 meses según el calendario obligatorio de la CSE.
BioNxt Solutions (OTCQB:BNXTF)가 Terry Lynch를 자본시장 자문으로 지속하고 두 명의 신규 투자자 관계 전문가를 채용했다고 발표했습니다. Power Metallic Mines의 CEO인 Terry Lynch는 자원 및 바이오 사이언스 분야의 초기 자본시장 실무 경험이 풍부합니다.
회사는 투자자 관계 서비스에 대해 6개월 기간으로 Rob Grace와 Blaine Ruzcki를 채용했습니다. Grace는 매월 CAD 20,000, Ruzcki는 매월 CAD 40,000를 받으며, GST가 추가됩니다. 각 전문가에게는 또한 1,000,000주식 옵션이 부여되며, 18개월 동안 행사 가능하고, 12개월 상향 배분 vesting 일정은 CSE의 의무 일정에 따릅니다.
BioNxt Solutions (OTCQB:BNXTF) a annoncé la prolongation de Terry Lynch en tant que conseiller des marchés de capitaux et la sécurisation de deux nouveaux professionnels des relations avec les investisseurs. Terry Lynch, PDG de Power Metallic Mines, apporte une expérience significative des marchés de capitaux en phase précoce dans les secteurs des ressources et de la biosciences.
L’entreprise a embauché Rob Grace et Blaine Ruzcki pour des services de relations avec les investisseurs sur une période de six mois. Grace percevra 20 000 CAD par mois, tandis que Ruzcki recevra 40 000 CAD par mois, plus la TPS. Chaque professionnel recevra également 1 000 000 d’options d’achat d’actions exerçables à 0,88 CAD pendant 18 mois, avec une acquisition (vesting) sur 12 mois selon le calendrier obligatoire du CSE.
BioNxt Solutions (OTCQB:BNXTF) hat die Fortsetzung von Terry Lynch als Berater für Kapitalmärkte angekündigt und die Anstellung von zwei neuen Investor-Relations-Profis bekanntgegeben. Terry Lynch, CEO von Power Metallic Mines, bringt erhebliche Erfahrungen aus den frühen Stadien der Kapitalmärkte in den Bereichen Ressourcen und Biowissenschaften mit.
Das Unternehmen hat Rob Grace und Blaine Ruzcki für Investor-Relations-Dienstleistungen über einen Zeitraum von sechs Monaten eingestellt. Grace wird CAD 20.000 pro Monat erhalten, während Ruzcki CAD 40.000 pro Monat plus GST erhält. Jeder Profi erhält außerdem 1.000.000 Aktienoptionen, exercisable zu 0,88 CAD über 18 Monate, vesting erfolgt über 12 Monate gemäß dem obligatorischen Schedule der CSE.
BioNxt Solutions (OTCQB:BNXTF) أعلنت عن استمرار تيري لينش كمستشار أسواق رأس المال واحتفاظها باثنين من المحترفين الجدد في العلاقات مع المستثمرين. تيري لينش، الرئيس التنفيذي لشركة Power Metallic Mines، يجلب خبرة كبيرة في أسواق رأس المال في المراحل المبكرة في قطاعات الموارد والعلوم الحيوية.
وقد وظّفت الشركة روب غريس وبلين Ruziك للخدمات المتعلقة بعلاقات المستثمرين لمدة ستة أشهر. سيتقاضى Grace 20,000 دولار كندي شهرياً بينما سيتقاضى Ruzcki 40,000 دولار كندي شهرياً، بالإضافة إلى ضريبة السلع والخدمات. كما سيحصل كل محترف أيضاً على مليون خيار أسهم قابلة للتنفيذ بسعر 0.88 دولار كندي لمدة 18 شهراً، مع vesting خلال 12 شهراً وفق الجدول الإلزامي لـ CSE.
BioNxt Solutions (OTCQB:BNXTF)宣布继续任命 Terry Lynch 为资本市场顾问并保留两名新的投资者关系专业人士。Terry Lynch 是 Power Metallic Mines 的首席执行官，在资源与生物科学领域的早期资本市场经验丰富。
公司已雇佣 Rob Grace 和 Blaine Ruzcki，为期六个月的投资者关系服务。Grace 的月薪为 CAD 20,000，Ruzcki 为 CAD 40,000，另加 GST。每位专业人士还将获得 1,000,000 股权激励期权，行使价为 0.88 CAD，期限为 18 个月，按 CSE 的强制时间表在 12 个月内归属（vest）完毕。
- None.
- None.
VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that Terry Lynch, CEO of Power Metallic Mines Inc. (TSX-V: PNPN), will continue his role as a capital markets advisor to the Company. Mr. Lynch brings decades of early-stage capital markets experience in the resource and bioscience sectors as well an extensive and influential international investment network.
The Company is also pleased to announce that it has retained two investor relations professionals, Rob Grace (401 -1400 View Crescent Delta, BC V4L 1Z1, robdgrace@gmail.com, 778.998.5431) and Blaine Ruzcki (Box 477 Okotoks, AB T1S 1A7, bruzycki@hotmail.com, 403.804.3213) to conduct promotional activities on behalf of BioNxt (the "Services") for a period of six months effective immediately. The Services include investor outreach and communication, distribution of Company information and news releases to proprietary networks, social media optimization, and general capital markets strategic advice. In consideration for the Services, Mr. Grace and Mr. Ruzcki will receive CAD 20,000 per month plus GST and CAD 40,000 per month plus GST, respectively. Pursuant to the Company's shareholder approved stock option plan, Mr. Grace and Mr. Ruzcki will also each receive 1,000,000 common share purchase options exercisable at
Neither Mr. Grace nor Mr. Ruzcki engage in market making activities and will restrict the Services to public relations and investor relations counseling.
About BioNxt Solutions Inc.
BioNxt Solutions Inc. is a bioscience innovator focused on next-generation drug delivery platforms, diagnostic screening systems, and active pharmaceutical ingredient development. Its proprietary platforms include sublingual thin films, transdermal patches, oral tablets, and a new targeted chemotherapy platform designed to deliver cancer drugs directly to tumors while reducing side effects.
With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes worldwide.
BioNxt is listed on the Canadian Securities Exchange: BNXT, OTC Markets: BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit www.bionxt.com.
BioNxt Solutions Inc.
Hugh Rogers, CEO and Director
Email: info@bionxt.com
Phone: +1 604-250-6162
Forward-Looking Information
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
This news release includes certain statements that may be deemed "forward-looking statements". All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
SOURCE: BioNxt Solutions Inc.
View the original press release on ACCESS Newswire
FAQ
Who are the new investor relations professionals hired by BioNxt Solutions (BNXTF)?
What compensation package did BioNxt (BNXTF) offer to its new IR professionals?
How will the stock options vest for BioNxt's (BNXTF) new IR professionals?
Who is continuing as capital markets advisor for BioNxt Solutions (BNXTF)?
